CSS
NTUS

Cubist Systematic Strategies’s Natus Medical Inc NTUS Stock Holding History

Cubist Systematic Strategies’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,137
Closed -$424K – 4733
2022
Q1 		$424K Sell
16,137
-6,501
-29% -$159K ﹤0.01% 2642
2021
Q4 		$537K Buy
22,638
+10,315
+84% +$255K 0.01% 2402
2021
Q3 		$309K Sell
12,323
-8,199
-40% -$209K ﹤0.01% 2341
2021
Q2 		$533K Buy
20,522
+2,454
+14% +$66.8K 0.01% 1968
2021
Q1 		$463K Sell
18,068
-25,578
-59% -$656K 0.01% 2000
2020
Q4 		$875K Buy
43,646
+19,503
+81% +$382K 0.01% 1464
2020
Q3 		$414K Sell
24,143
-18,101
-43% -$342K 0.01% 1851
2020
Q2 		$922K Buy
42,244
+25,551
+153% +$585K 0.02% 1232
2020
Q1 		$386K Buy
16,693
+8,005
+92% +$233K 0.01% 1388
2019
Q4 		$287K Buy
+8,688
New +$278K 0.01% 1864
2019
Q3 		– Sell
-16,093
Closed -$413K – 2591
2019
Q2 		$413K Sell
16,093
-10,509
-40% -$268K 0.01% 1609
2019
Q1 		$675K Buy
26,602
+25,102
+1,673% +$749K 0.02% 992
2018
Q4 		$51K Buy
+1,500
New +$48.8K ﹤0.01% 1863
2018
Q1 		– Sell
-5,856
Closed -$224K – 2149
2017
Q4 		$224K Buy
+5,856
New +$234K 0.01% 1457
2017
Q3 		– Sell
-3,199
Closed -$119K – 2059
2017
Q2 		$119K Sell
3,199
-2,551
-44% -$92.2K 0.01% 1423
2017
Q1 		$226K Sell
5,750
-11,656
-67% -$437K 0.02% 1100
2016
Q4 		$606K Buy
+17,406
New +$683K 0.05% 574
2016
Q3 		– Sell
-101
Closed -$4K – 1925
2016
Q2 		$4K Sell
101
-5,503
-98% -$184K ﹤0.01% 1679
2016
Q1 		$215K Buy
+5,604
New +$209K 0.01% 1180
2015
Q2 		– Sell
-24,755
Closed -$977K – 2111
2015
Q1 		$977K Buy
+24,755
New +$913K 0.05% 582
2014
Q3 		– Sell
-20,621
Closed -$518K – 1924
2014
Q2 		$518K Buy
+20,621
New +$510K 0.03% 730

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's NTUS Position: Q2 2022 in Review

Cubist Systematic Strategies sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 16,137 shares — an estimated $424K sold.

Cubist Systematic Strategies first reported a position in NTUS in Q2 2014 and held it in 21 quarters. The position peaked at $977K in Q1 2015. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

  • Cubist Systematic Strategies reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 16,137 Natus Medical Inc shares in Q2 2022, an estimated $424K.
  • Cubist Systematic Strategies first reported a position in Natus Medical Inc in Q2 2014 and held it in 21 quarters.
  • Cubist Systematic Strategies's Natus Medical Inc position peaked at $977K in Q1 2015.
  • 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Cubist Systematic Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.